您当前的位置：
首页 >
文章列表页 >
Molecular biology basis and therapeutic advances in BRAF V600E-mutant metastatic colorectal cancer
Review | 更新时间：2026-04-17

    • Molecular biology basis and therapeutic advances in BRAF V600E-mutant metastatic colorectal cancer

    • Chin Oncol   Vol. 36, Issue 3, Pages: 278-289(2026)

    • DOI：10.19401/j.cnki.1007-3639.2026.03.008    

      CLC： R735.3

    • Received：10 September 2025，

      Revised：2025-11-18，

      Published：30 March 2026

    移动端阅览

  • ZHOU J J, HONG Y G, LIU P, et al. Molecular biology basis and therapeutic advances in BRAF V600E-mutant metastatic colorectal cancer［J］. China Oncol, 2026, 36(3): 278-289. DOI： 10.19401/j.cnki.1007-3639.2026.03.008.

  •  
  •  

0

Views

2

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Targeted therapy and immunotherapy combined with chemotherapy bring effective response to AFP positive colon cancer patients: a case report and literature review
Progress and future directions of important clinical trial on breast cancer in China in 2025
Research status and progress of third-line treatment for metastatic colorectal cancer
Advances and future perspectives of neoadjuvant immunotherapy in colorectal cancer
Effectiveness and safety analysis of camrelizumab combined with chemotherapy and targeted therapy in patients with recurrent, metastatic, and treatment-naive advanced cervical cancer: a retrospective cohort study

Related Author

LIU Miao
LI Jinze
WU Chensi
ZHANG Fengbin
GAO Hongsheng
ZHANG Ruixing
DONG Zixian
LI Zhedong

Related Institution

Department of Gastroenterology, the Fourth Hospital of Hebei Medical University
Department of Pathology, the Fourth Hospital of Hebei Medical University
Department of Breast Surgery, the First Affiliated Hospital of China Medical University
Department of Oncology, The First Affiliated Hospital of Naval Medical University
Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
0